eMAPS 3
Market Access for Partners
Challenge
eMAPS 3 targets entrepreneurs, innovators, SMEs and others in the life science sector. Gives entrepreneurs and SMEs access to practical knowledge that can be applied to gain market access, allowing them to bring products to market in a sustainable and cost-effective way. Through this platform aims to accelerate innovation adoption to improve the health of European citizens. eMAPS 3 covers the area of the drugs and biotech products; medical devices and diagnostics; and digital health solutions.
Solution
The eMAPs platform is an innovative learning portal to support entrepreneurs and innovators to navigate the complex processes and pathways involved in accessing healthcare markets (drugs and biotech products; medical devices and diagnostics; and digital health solutions) across Europe. The eMAPS 3 proposal will further develop the platform by adding much needed information on Germany, Italy and Portugal as well as the US.
Project Reference
19113Funding
EIT Health
Location
EuropeTotal Cost
614.339.00IPN Cost
614.339.00EU financial support
614.339.00National public financial support
60.000.00Duration
12 mesesConsortium
0005 - Achmea Zorgverzekeringen NV.0013 - Friedrich-Alexander-Universität Erlangen-Nürnberg
0013-1 - Universitätsklinikum Erlangen
0091 - Instituto Pedro Nunes
0108 - Oxford University Hospitals NHS Foundation Trust
0152 - Universitá degli Studi Di Napoli Federico II (Unina)
